Recent research highlights a method that disrupts the interaction between two key proteins, offering a more precise and ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

Proton pump inhibitors are a class of medications used to treat conditions like GERD and ulcers. They work by blocking the ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in ... of a protein called PKCλ/ι in prostate cancer cells enables EZH2 to drive aggressive growth, even with androgen ...

The Zoghbi lab had earlier identified TYK2 – an enzyme that adds phosphate to Tyrosine groups – as a potential regulator ... "Although much work is needed, our findings suggest that partial inhibition ...

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

Scientists have discovered that the enzyme TYK2 modifies tau proteins, leading to their accumulation in the brain—a key ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.